| N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia F Jessen, N Fingerhut, AM Sprinkart, KU Kühn, N Petrovsky, W Maier, ... Schizophrenia bulletin 39 (1), 197-205, 2013 | 87 | 2013 |
| Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-< i> O</i>-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study BB Quednow, A Schmechtig, U Ettinger, N Petrovsky, DA Collier, ... Biological psychiatry 66 (6), 614-620, 2009 | 84 | 2009 |
| Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers N Petrovsky, BB Quednow, U Ettinger, A Schmechtig, R Mössner, ... Neuropsychopharmacology 35 (7), 1429-1439, 2010 | 80 | 2010 |
| Neurocognitive impairments in non‐deprived smokers—results from a population‐based multi‐center study on smoking‐related behavior M Wagner, S Schulze‐Rauschenbach, N Petrovsky, J Brinkmeyer, ... Addiction biology 18 (4), 752-761, 2013 | 76 | 2013 |
| Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating BB Quednow, J Brinkmeyer, A Mobascher, M Nothnagel, F Musso, ... Proceedings of the National Academy of Sciences 109 (16), 6271-6276, 2012 | 65 | 2012 |
| The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response L Lennertz, BB Quednow, A Schuhmacher, N Petrovsky, I Frommann, ... preparation 5 (6), 7, 2012 | 35 | 2012 |
| Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy N Petrovsky, U Ettinger, BB Quednow, H Walter, K Schnell, H Kessler, ... Psychopharmacology 221 (1), 27-38, 2012 | 32 | 2012 |
| Nicotine Differentially Modulates Antisaccade Performance in Healthy Male Non-Smokers Stratified for Low and High Accuracy N Petrovsky, U Ettinger, H Kessler, R Moessner, W Maier, M Wagner BIOLOGICAL PSYCHIATRY 69 (9), 236S-236S, 2011 | 32* | 2011 |
| Sustained incentive value of heroin-related cues in short-and long-term abstinent heroin users KH Preller, M Wagner, C Sulzbach, K Hoenig, J Neubauer, PE Franke, ... European Neuropsychopharmacology 23 (10), 1270-1279, 2013 | 31 | 2013 |
| Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls N Petrovsky, U Ettinger, BB Quednow, MW Landsberg, J Drees, ... The International Journal of Neuropsychopharmacology 16 (07), 1473-1481, 2013 | 29 | 2013 |
| Functional polymorphism in the Neuropeptide Y Gene Promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women J Mutschler, E Abbruzzese, K Wiedemann, C von der Goltz, C Dinter, ... Annals of Nutrition and Metabolism 62 (4), 271-276, 2013 | 26 | 2013 |
| Antisaccade performance is related to genetic loading for schizophrenia N Petrovsky, F Weiss-Motz, S Schulze-Rauschenbach, M Lemke, ... Journal of psychiatric research 43 (3), 291-297, 2009 | 25 | 2009 |
| Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking J Mutschler, E Abbruzzese, C von der Goltz, C Dinter, A Mobascher, ... European addiction research 18 (5), 246-252, 2012 | 21 | 2012 |
| The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism N Petrovsky, U Ettinger, H Kessler, R Mössner, S Wolfsgruber, N Dahmen, ... Psychopharmacology 229 (1), 31-40, 2013 | 19 | 2013 |
| CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance N Petrovsky, A Schmechtig, RH Flomen, V Kumari, D Collier, A Makoff, ... The International Journal of Neuropsychopharmacology 12 (02), 267-273, 2009 | 12 | 2009 |
| Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case–control study J Mutschler, E Abbruzzese, C von der Goltz, C Dinter, A Mobascher, ... Nicotine & Tobacco Research 15 (7), 1322-1327, 2013 | 10 | 2013 |
| Antisaccade deficits in subjects either genetically or clinically at risk for schizophrenia M Wagner, N Petrovsky, J Brinkmeyer, W Wölwer, A Bechdolf, ... Schizophrenia Research 102 (1), 13, 2008 | 1* | 2008 |
| Motivational Modulation of the Attentional Blink N Petrovsky | 1 | 2006 |
| Cholinergic modulation of antisaccade performance: The role of CHRFAM7A polymorphisms and differential effects of nicotine as a function of baseline performance N Petrovsky Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Diss., 2012, 2012 | | 2012 |
| Nicotine effects on endophenotypes of schizophrenia N Petrovsky, U Ettinger, B Quednow, K Schnell, R Mössner, H Walter, ... Pharmacopsychiatry 42 (05), A126, 2009 | | 2009 |
